News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,046 Results
Type
Article (8038)
Company Profile (140)
Press Release (476963)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166748)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52876)
Employer Resources (14)
FDA (9760)
Job Trends (8575)
News (238194)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33161)
ALS (105)
Alzheimer's disease (980)
Antibody-drug conjugate (ADC) (272)
Approvals (10391)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (208)
Automation (28)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (112)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (515)
Cancer (3684)
Cardiovascular disease (221)
Career advice (247)
Career pathing (2)
CAR-T (175)
CDMO (8)
Celiac Disease (1)
Cell therapy (479)
Cervical cancer (34)
Clinical research (47927)
Collaboration (1253)
Commercialization (3)
Compensation (1477)
Complete response letters (34)
COVID-19 (759)
CRISPR (64)
C-suite (760)
Cystic fibrosis (85)
Data (5720)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (344)
Diagnostics (4192)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73733)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87758)
Executive appointments (707)
FDA (12426)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (927)
Gene editing (126)
Generative AI (9)
Gene therapy (322)
GLP-1 (291)
Government (955)
Grass and pollen (2)
Guidances (281)
Healthcare (9342)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (59)
Indications (157)
Infectious disease (947)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (258)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Labor market (1)
Layoffs (60)
Legal (5209)
Licensing (11)
Liver cancer (45)
Longevity (18)
Lung cancer (513)
Lymphoma (253)
Machine learning (27)
Management (3)
Manufacturing (539)
Marketing (8)
MASH (118)
Medical device (8664)
Medtech (8811)
Mergers & acquisitions (14392)
Metabolic disorders (709)
mRNA (59)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1836)
NextGen: Class of 2026 (3154)
Non-profit (847)
Obesity (225)
Opinion (10)
Ovarian cancer (160)
Pain (173)
Pancreatic cancer (201)
Parkinson's disease (201)
Partnered (12)
Patents (480)
Patient recruitment (514)
Peanut (31)
People (41282)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15477)
Phase 2 (21398)
Phase 3 (14430)
Pipeline (7450)
Policy (18)
Postmarket research (1572)
Preclinical (6542)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (577)
Real estate (3022)
Recruiting (6)
Regulatory (14876)
Reports (21)
Research institute (583)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (157)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (50)
Vaccines (331)
Venture capital (17)
Weight loss (73)
Women's health (82)
Date
Today (107)
Last 7 days (293)
Last 30 days (1571)
Last 365 days (19008)
2026 (12682)
2025 (19251)
2024 (22986)
2023 (26541)
2022 (34586)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17468)
2017 (18766)
2016 (17920)
2015 (24269)
2014 (21679)
2013 (18139)
2012 (20222)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (74)
Alaska (2)
Arizona (306)
Arkansas (11)
Asia (17919)
Australia (2101)
California (12077)
Canada (3176)
China (530)
Colorado (488)
Connecticut (414)
Delaware (208)
Europe (24649)
Florida (1809)
Georgia (386)
Hawaii (3)
Idaho (46)
Illinois (707)
India (51)
Indiana (317)
Iowa (15)
Japan (412)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1208)
Massachusetts (7915)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (117)
New Hampshire (60)
New Jersey (2638)
New Mexico (12)
New York (2835)
North Carolina (1293)
North Dakota (4)
Northern California (6063)
Ohio (281)
Oklahoma (14)
Oregon (16)
Pennsylvania (2267)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5014)
Tennessee (122)
Texas (1959)
United States (39182)
Utah (363)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (933)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,046 Results for "vgxi inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Stephanie Burke Named as VGXI’s New Chief Accounting Officer
VGXI, Inc., a leading contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is pleased to announce the appointment of Stephanie Burke as the Chief Accounting Officer for VGXI.
March 27, 2024
·
3 min read
Business
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc. has entered into a strategic partnership with Sutro Biopharma, Inc. to support clinical production of luveltamab tazevibulin, abbreviated as “luvelta”, a novel Folate Receptor-α -targeting antibody-drug conjugate with the potential to address the unmet need in several FRα-expressing cancers.
June 3, 2024
·
4 min read
Business
VGXI Announces Strategic Multi-Year Partnership with Resilience to Accelerate Biomanufacturing of Advanced Medicines
VGXI, Inc. have entered a strategic multi-year partnership.
January 24, 2024
·
3 min read
Business
VGXI Welcomes Michael Stewart as New Chief Operating Officer
VGXI, Inc., a leading contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, proudly announces the appointment of Michael Stewart as its new Chief Operating Officer.
March 4, 2024
·
3 min read
Drug Development
VGXI, Inc. Establishes Pilot mRNA Manufacturing Capabilities
Under a Technology License Agreement with the Houston Methodist Research Institute, Contract Developer and Manufacturer VGXI Achieves Key Milestones with Establishment of Pilot Production Capabilities for RNA-Based Medicines.
December 9, 2019
·
5 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
Job Trends
VGXI Selects BE&K as Design-Build Partner for New Manufacturing Facility
Plasmid DNA Manufacturer VGXI, Inc. Selects BE&K Building Group as its Design-Build Partner for the Initial Phase of its New and Expanded Manufacturing Facility
December 4, 2019
·
5 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 48,505
Next
